StonvexLoading…
StonvexCore line items from TLRY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-27 | Q1 2026 2026-02-28 | Q4 2025 2025-11-30 | Q3 2025 2025-08-31 | Annual 2025 2025-05-31 |
|---|---|---|---|---|---|
Revenue | $251.13M | $633.74M | $427.01M | $209.50M | $821.31M |
Operating Income | Not available | $-46.57M | $-20.19M | $2.09M | $-2.28B |
Net Income | Not available | $-71.83M | $-45.25M | $-322.00K | $-2.19B |
EPS (Diluted) | $-0.01 | $-0.65 | $-0.42 | $0.00 | $-2.46 |
Total Assets | Not available | $2.07B | $2.10B | $2.08B | $2.07B |
Total Liabilities | Not available | $549.12M | $552.09M | $561.99M | $584.75M |
Cash & Equivalents | Not available | $204.62M | $246.70M | $264.83M | $221.67M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | $-127.52M |
Shares Outstanding | Not available | 116.55M | 116.52M | 1.12B | 106.07M |